CURE - Citizens United for Research in Epilepsy It's Time We Found a CURE CURE Epilepsy Research

The Center for SUDEP Research

GrantsThe Center for SUDEP Research (CSR) is pleased to announce “The NINDS Center for SUDEP Research Pilot.”

The CSR seeks novel pilot projects that will address the goal of understanding and eliminating SUDEP. This pilot program will award grants to researchers submitting innovative proposals that compliment and expand on the SUDEP research proposed in the CSR. The CSR plans to support one basic science pilot project and one clinical pilot project (clinical trials will not be funded through this mechanism, but studies involving human subjects are allowed). Successful applicants will be expected to work collaboratively with the CSR investigators.

This award is available to both young and established investigators exploring cutting-­-edge to understanding and preventing human SUDEP. International applicants and applicants from outside the field of epilepsy with novel insight into the causes and prevention of SUDEP are welcome. Investigators already funded by the CSR are not eligible to apply. All materials must be submitted in English.

The 2015 application deadline is APRIL 29, 2015.

Click here for more details and to apply

Mallinckrodt Pharmaceuticals

GrantsThe following opportunity is now available for Spring 2015:

Mallinckrodt Pharmaceuticals is pleased to announce the Research Fellowship Award Program will continue in 2015. There will be 25 total positions funded in a variety of disease states, including several within Neurology, with a focus on Infantile Spasms. The objective of the program is to provide grants to academic or non-profit institutions and research personnel, such as fellows, junior clinicians, residents and post-doctoral researchers pursuing a research-oriented career in the area of clinical, translational, or basic research. Research will be conducted at eligible institutions and fulfills an unmet medical need or addresses essential scientific questions in areas to include Infantile Spasms. The award amount is $80,000/year for 2 years with the second year contingent on the research progress made in Year 1.

As the Autoimmune and Rare Diseases business within Mallinckrodt Pharmaceuticals’ Specialty Brands segment, we focus on the treatment of patients with serious autoimmune and inflammatory disorders. In particular, we place an emphasis on the fields of neurology, nephrology, rheumatology and pulmonology: all of which are areas with significant unmet medical needs. Thank you for your interest and we look forward to reviewing your application.

The 2015 application deadline is MAY 30, 2015 and the funds will be dispersed to the awardee's institution by July 31, 2015.

Click here for more details and to apply

Epilepsy Foundation

The following opportunities are now available for Spring 2015:

  • Epilepsy Foundation - New Therapy Commercialization Grants Program - New Therapy Commercialization Grants Program supports the development of more effective therapies by serving as a catalyst for moving innovative therapies from the laboratory to the patient.
  • Epilepsy Innovation Seal of Excellence Award - The program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices.
  • Targeted Research Initiative for Morbidity and Mortality - This initiative supports research that generates initial data leading to more extensive projects that will generate knowledge that will ultimately improve the lives of persons with epilepsy.

Click here for more details about these programs

GrantsGlobal Brain Disorders Research

The ILAE and its Commission on Neurobiology would like to let you know of a significant funding opportunity for international collaborative projects on brain disorders, including epilepsy.

The Fogarty International Center of the U.S. National Institutes of Health has announced its renewal of the Global Brain Disorders Research. This program supports collaborative research involving institutions in low income countries with upper income countries as defined by the World Bank.

The grants require the involvement of an institution from an upper or upper middle income countries and an institution from a lower or lower middle income nation.

Click here for more details about the program

National Institutes of Health (NIH)

Centers Without Walls for Collaborative Research in the Epilepsies: Developing Disease Modifying or Prevention Therapies (U54)

The ultimate goal of this Epilepsy Center Without Walls (CWOW) is to facilitate development of a first-in-class disease modifying or prevention therapy for epilepsy. The CWOW award(s) will support the clinical and/or preclinical studies necessary to overcome the key limitations that prevent proposed interventions from immediately entering translational development or clinical testing.

A required shared resource Core will enable additional investigators outside the CWOW to benefit from the expertise and infrastructure built in the CWOW. The award will also support public engagement activities among investigators, people with epilepsy, caregivers, and epilepsy-related voluntary organizations to support these partnerships in clinical research and future trials.

Click here for more info and to apply




CURE For questions, please contact Julie Milder at the CURE office, 312.255.1801, or email

CURE Epilepsy
Related:     Take Action  
The State of Epilepsy

The State of Epilepsy

Read More

Our Researchers

Grant Recipients

Read More

Other Grant Opportunities

Other Grants

Read More

CURE epilepsy

Every Dollar Counts


So Many Ways You Can Help


Get the Facts